Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rational use of polymyxin B in multidrug‑resistant bacterial infections (real‑world study)
ChiCTR2200064300Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Oct 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of polymyxin B in Infection (2 arms), sponsored by Second Hospital of Shandong University. Primary endpoint: mortality. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
polymyxin B
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR2200064300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064300.